CLINICAL TRIAL: PHASE I/II STUDY OF A BOOSTER DOSE OF A/H5N1/INDONESIA/05/05 (CL

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 这是一项NIH赞助的多中心1-2期试验，比较了进化枝2型禽流感疫苗与安慰剂在先前接受进化枝1型疫苗的受者中的安全性和免疫应答。 受试者随机接受低剂量（15 μ g）或高剂量（90 μ g）疫苗。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This is an NIH-sponsored multi-center phase 1-2 trial comparing the safety and immune responses of a clade 2 avian influenza vaccine in prior recipients of a clade 1 vaccine versus placebo. Subject are randomized to get either a low dose (15 ¿g) or a high dose (90 ¿g) of the vaccine.